Literature DB >> 25225836

Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study.

Jacobo Cambil-Martín, Noelia Galiano-Castillo, Elena Muñoz-Hellín, Lourdes Díaz-Rodríguez, Sofía Laguarta-Val, César Fernández-de-Las-Peñas, Manuel Arroyo-Morales.   

Abstract

OBJECTIVES: To analyze the effect of weight on psychological and functional outcomes in multiple sclerosis (MS) patients, including self-perception, depression, functional level, fatigue, and self-rated health status.
METHODS: One hundred and one (n = 101) patients with MS participated in this cross-sectional study. Outcomes were scores in the Beck Depression Inventory, NEO Five-Factor Inventory (NEOFFI), Functional Assessment of Multiple Sclerosis (FAMS), Fatigue Impact Scale, and Quality Short-Form Health Survey 36 (SF-36). Patients were classified as normal weight (18.5 < BMI < 24.9 kg/m(2)) or overweight (25.0 > BMI > 29.9 kg/m(2)). One-way analysis of covariance was conducted with gender, age, and years with disease as covariates.
RESULTS: Depression levels were significantly higher in overweight versus normal-weight MS patients (F = 6.381; P = 0.013). NEOFFI scores were significantly higher in overweight versus normal-weight MS patients for extraversion (F = 6.331; P = 0.014), conscientiousness (F = 4.794; P = 0.034), and neuroticism (F = 5.422; P = 0.022) but not for openness (F = 2.174; P = 0.109) or agreeableness (F = 0.047; P = 0.829). The two groups did not significantly differ in fatigue (P > 00.5). Scores in general (F = 4.708; P = 0.032) and mental health (F = 4.583; P = 0.035) SF-36 domains were significantly lower in overweight versus normal-weight patients. Scores for FAMS domains of emotional well-being (F = 8.050; P = 0.006), general contentment (F = 7.967; P = 0.006), and family/social well-being (F = 7.662; P = 0.007) were significantly lower in overweight versus normal-weight patients.
CONCLUSIONS: Overweight MS patients evidenced higher depression levels, lower functional capacity, and worse self-rated health status in comparison to normal-weight MS patients. These results suggest that weight control programs should be incorporated into the management of patients with MS.

Entities:  

Keywords:  Depression; Fatigue; Multiple sclerosis; Overweight; Quality of life

Mesh:

Year:  2014        PMID: 25225836     DOI: 10.1179/1476830514Y.0000000156

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  4 in total

1.  Multiple Sclerosis, Anxiety, and Depression in the United Arab Emirates: Does Social Stigma Prevent Treatment?

Authors:  Nicoline Schiess; Katherine Huether; Kathryn B Holroyd; Faisal Aziz; Essam Emam; Tarek Shahrour; Miklos Szolics; Taoufik Alsaadi
Journal:  Int J MS Care       Date:  2019 Jan-Feb

Review 2.  Multiple Sclerosis and Obesity: Possible Roles of Adipokines.

Authors:  José de Jesús Guerrero-García; Lucrecia Carrera-Quintanar; Rocío Ivette López-Roa; Ana Laura Márquez-Aguirre; Argelia Esperanza Rojas-Mayorquín; Daniel Ortuño-Sahagún
Journal:  Mediators Inflamm       Date:  2016-09-18       Impact factor: 4.711

3.  Demographic and Life Styles Determinants of Somatic Complaints' Structures: A Cross-sectional Study on a Large Sample of Iranian Adults Using Factor Mixture Model.

Authors:  Zahra Heidari; Awat Feizi; Hamidreza Roohafza; Ammar Hassanzadeh Keshteli; Fatemeh Zahra Shiravi; Payman Adibi
Journal:  Int J Prev Med       Date:  2017-02-20

4.  The Effect of Body Mass Index on Brain Volume and Cognitive Function in Relapsing-Remitting Multiple sclerosis: A CombiRx Secondary Analysis.

Authors:  Aliza Bitton Ben-Zacharia; Malvin N Janal; Abraham A Brody; Jerry Wolinsky; Fred Lublin; Gary Cutter
Journal:  J Cent Nerv Syst Dis       Date:  2021-11-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.